title: Organizing pneumonia with fatal outcome after adjuvant chemotherapy with FOLFOX.
authors.affiliation: Servicio Oncología Radioterápica, Hospital Clínic de Barcelona, Barcelona, España. Electronic address: wavargas@clinic.ub.es.
authors.forename: Andrés
authors.initials: A
authors.lastname: Vargas
authors.affiliation: Servicio de Anatomía Patológica, Hospital Clínic de Barcelona, Barcelona, España.
authors.forename: Carla
authors.initials: C
authors.lastname: Montironi
authors.affiliation: Servicio de Oncología Médica, Hospital Clínic de Barcelona, Barcelona, España.
authors.forename: Elvira
authors.initials: E
authors.lastname: Buxó
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects*; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D018549:Cryptogenic Organizing Pneumonia / Q000175:diagnosis / Q000209:etiology*; D017809:Fatal Outcome; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects; D017563:Lung Diseases, Interstitial / Q000175:diagnosis; D008297:Male; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil